Saturday, May 21, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

by Medical Finance
in News
Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Dotphoton, an industry-leading raw image compression company and Hamamatsu Photonics, a world leader in optical systems and photonics manufacturing, are pleased to announce their new partnership.

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

Research sample by Wyss Center for Bio and Neuroengineering. Acquired on Hamamatsu ORCA-Flash 4.0 and compressed with Jetraw. Image Credit: Hamamatsu Photonics Europe

Modern microscopy, drug discovery and cell research are among the many applications that rely on the highest quality image data. Hamamatsu, a  renowned scientific camera manufacturer, provides the ultimate image quality needed for scientific research and pharmaceutical industry in fields such as light-sheet microscopy, high-throughput screening, and histopathology.

In these applications, the generation of large volumes of data leads to low scalability and high costs and complexity of required IT infrastructure. This new partnership enables researchers to capture and preserve higher volumes of quality data, and to make the most of modern processing methods, including AI-based image processing.

In industry and academia, storage budgets grow exponentially every year, the increase of datacenter costs and its CO2 impact reduce the amount of resources available for research. We have built Jetraw to address all these problems at once, and are very happy to partner with Hamamatsu Photonics to make large image data more reliable and sustainable, and help many wonderful discoveries to happen”

Eugenia Balysheva, CEO, Dotphoton

Hamamatsu offers advanced imaging technology on the forefront of the development of new and existing scientific applications. Today, Hamamatsu’s ORCA cameras are compatible with Dotphoton’s Jetraw software. Thanks to this new partnership, Hamamatsu will be able to support customers in their data management, an additional benefit to the high-sensitivity, fast readout speeds, and low noise delivery of its scientific CMOS cameras.

The Jetraw software provides the highest raw image compression ratio in the market combined with the highest processing speed. That means that Hamamatsu camera users can benefit from the fully preserved raw image data without constraints linked to storage and data transfer speed. Jetraw enables reduction of storage costs by 80%, CO2 emissions by 73%, and data transfer speed by 5-7x.

At Hamamatsu, our aim is to support customers achieve their ambitions. In the case of our scientific research customers, we understood the need for them to easily share and manage their ever-increasing data creation. Our scientific cameras produce incredibly fast, quantitative imagery that our customers develop at a high volume. Thanks to our new partnership with Dotphoton, we can support our customers one step further by offering them the possibility to reduce their file sizes without ever compromising the quality of their work. We look forward to this collaboration and the exciting possibilities now presented to our customers.”

Marco Mayer, The Strategic Business Development Manager, Hamamatsu Europe

Jetraw software is available for the range of Hamamatsu ORCA cameras, and can be purchased at the Jetraw.com website. Jetraw is compatible with most popular image processing workflows and enables long-term scalability and reliability of image processing.

“Working in developmental biology we need to acquire large time-lapse movies to capture the dynamics of the growing zebrafish embryo. We struggle to interact with our tera-byte size data due to slow data transfer and expensive storage. With Jetraw’s compression (from 913GB to 115GB per movie, as an example) we solved these issues with the perk of not losing any information on the data even when performing our routine analysis.” Arianne Bercowsky, Oates Group, EPFL, Switzerland – a user of a Hamamatsu ORCA-Fusion BT camera within Viventis LS1 Live Light Sheet Microscope System.

Source:

Hamamatsu Photonics Europe

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Scientists unravel how blood cells mount the first line of defense against viruses

‘Decoy’ protein mitigates lung damage, death induced by aggressive SARS-CoV-2 variants

by Medical Finance
May 20, 2022
0

A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in...

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

by Medical Finance
May 21, 2022
0

From AcetoJan 27 2022Reviewed by Louis Castel Aceto, a leading global provider of specialty materials for life sciences and advanced...

Researchers investigate how messenger substances signal inflammation during damaged cell removal

Viral microRNA acts as a master regulator to induce the reactivation of dormant herpesviruses

by Medical Finance
May 20, 2022
0

Dormant herpesviruses induce their reactivation via a previously unknown cellular mechanism mediated by a viral microRNA. Würzburg researchers show this...

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Researchers pursue a new way to use milk for delivering cancer-fighters to the brain

by Medical Finance
May 20, 2022
0

In health care, perhaps no word sends a more chilling message than "cancer." Brain tumors, for example, prove especially resistant...

Ocean living microbes make oxygen in the dark

New findings could contribute to future therapeutics for muscle degeneration

by Medical Finance
May 20, 2022
0

An international team led by uOttawa Faculty of Medicine researchers have published findings that could contribute to future therapeutics for...

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

Targeting CHI3L1 inhibits SARS-CoV-2 variants, including Delta and Omicron

by Medical Finance
May 20, 2022
0

The coronavirus disease 2019 (COVID-19) is caused by infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which has created...

Next Post
Scientists unravel how blood cells mount the first line of defense against viruses

Genome research explains why oats could be suitable for most people with celiac disease

Swapping single food item for a more planet-friendly alternative could reduce diet’s carbon footprint

First large-scale estimate of live microbes consumed by Americans daily

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Natural Killer NK cell identifies cancer cell Illustration Alpha Tauri 3D Graphics M1 df26c964f0144a8b912d9638f99be561 620x480
    A kind of kiss between cells plays key role in the fight between immune system and blood cancer cells
  • 163926142 620x480
    Study finds elevated inflammation in macrophages months after mild COVID-19
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply